Cargando…
Synthetic lethality guiding selection of drug combinations in ovarian cancer
BACKGROUND: Synthetic lethality describes a relationship between two genes where single loss of either gene does not trigger significant impact on cell viability, but simultaneous loss of both gene functions results in lethality. Targeting synthetic lethal interactions with drug combinations promise...
Autores principales: | Heinzel, Andreas, Marhold, Maximilian, Mayer, Paul, Schwarz, Michael, Tomasich, Erwin, Lukas, Arno, Krainer, Michael, Perco, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347359/ https://www.ncbi.nlm.nih.gov/pubmed/30682083 http://dx.doi.org/10.1371/journal.pone.0210859 |
Ejemplares similares
-
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast
por: Marhold, Maximilian, et al.
Publicado: (2018) -
Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer
por: Andorfer, Peter, et al.
Publicado: (2016) -
Linking the ovarian cancer transcriptome and immunome
por: Rapberger, Ronald, et al.
Publicado: (2008) -
MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice
por: Marhold, Maximilian, et al.
Publicado: (2022) -
From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action
por: Heinzel, Andreas, et al.
Publicado: (2014)